USANA HEALTH SCIENCES INC
For the period ended Apr 30, 2024. Filed Apr 30, 2024.
View on SEC.govAbout this filing
A notice of a major event between regular reports, such as results, a deal or a change of executives. It is often the first formal record of the news.
Apr 30, 2024 · Filed Apr 30, 2024
USNA$13.63-1.7%Stored close · as of Nov 6, 2026
Contents
EX-99.1 · (in thousands, except per share data)
(in thousands, except per share data)
| Quarter Ended | ||
|---|---|---|
| March 30,2024 | April 1,2023 | |
| Net sales | $227,800 | $248,360 |
| Cost of sales | 43,069 | 48,519 |
| Gross profit | 184,731 | 199,841 |
| Operating expenses: | ||
| Associate incentives | 95,758 | 106,070 |
| Selling, general and administrative | 64,300 | 66,926 |
| Total operating expenses | 160,058 | 172,996 |
| Earnings from operations | 24,673 | 26,845 |
| Other income (expense): | ||
| Interest income | 2,676 | 1,775 |
| Interest expense | (52) | (31) |
| Other, net | (186) | (88) |
| Other income (expense), net | 2,438 | 1,656 |
| Earnings before income taxes | 27,111 | 28,501 |
| Income taxes | 10,574 | 10,118 |
| Net earnings | $16,537 | $18,383 |
| Earnings per common share | ||
| Basic | $0.86 | $0.95 |
| Diluted | $0.86 | $0.95 |
| Weighted average common shares outstanding | ||
| Basic | 19,174 | 19,283 |
| Diluted | 19,302 | 19,328 |
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.